Lasvegas-desktop
Las-Vegas-NV

Primary Hyperoxaluria Type 1 (PH1)

American Urological Association (AUA) 2025

Congress Details

calanderApril 26-29, 2025

locationLas Vegas, NV, USA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Congress Materials

Image
icon Presentation Type
Presentation
Image
location icon Location
Las Vegas, NV, USA
Image
icon Title
Long-term effects of lumasiran on kidney stones and nephrocalcinosis in patients with primary hyperoxaluria type 1